Toggle navigation
About
Abstract
Editorial Board
Publication Schedule
Subscription & Newsletter
Contact
Issues
This issue
25-3
All issues
Download PDF
Download EPUB
Editor's Selection
This issue
25-3
Browse by topic
Browse by contributor
Dialogue & Opinion
Abstracts
Abstracts
Search
Classification List
Abstracted Journals
Index of Authors
News & Reports
Home
Abstracts
Index of Authors
Author #124583
advertisement
Kong MD
17
Showing records 1 to 17 |
Display all abstracts from
Kong MD
128109
Ellipsoid Zone Loss as an Outcome Measure in MAK-Associated Retinitis Pigmentosa
Kong MD
American Journal of Ophthalmology
2025; 278: 282-291
128162
Divergent Manifestations in Biallelic Versus Monoallelic Variants of RP1-, BEST1-, and PROM1-Associated Retinal Disorders
Kong MD
International journal of molecular sciences
2025; 26:
128109
Ellipsoid Zone Loss as an Outcome Measure in MAK-Associated Retinitis Pigmentosa
Kong MD
American Journal of Ophthalmology
2025; 278: 282-291
128162
Divergent Manifestations in Biallelic Versus Monoallelic Variants of RP1-, BEST1-, and PROM1-Associated Retinal Disorders
Kong MD
International journal of molecular sciences
2025; 26:
128109
Ellipsoid Zone Loss as an Outcome Measure in MAK-Associated Retinitis Pigmentosa
Bailey JA
American Journal of Ophthalmology
2025; 278: 282-291
128162
Divergent Manifestations in Biallelic Versus Monoallelic Variants of RP1-, BEST1-, and PROM1-Associated Retinal Disorders
Golebka J
International journal of molecular sciences
2025; 26:
128109
Ellipsoid Zone Loss as an Outcome Measure in MAK-Associated Retinitis Pigmentosa
Exinor A
American Journal of Ophthalmology
2025; 278: 282-291
128162
Divergent Manifestations in Biallelic Versus Monoallelic Variants of RP1-, BEST1-, and PROM1-Associated Retinal Disorders
Anderson VR; Bao C; Bao C
International journal of molecular sciences
2025; 26:
128109
Ellipsoid Zone Loss as an Outcome Measure in MAK-Associated Retinitis Pigmentosa
Heaps N
American Journal of Ophthalmology
2025; 278: 282-291
128162
Divergent Manifestations in Biallelic Versus Monoallelic Variants of RP1-, BEST1-, and PROM1-Associated Retinal Disorders
Bailey JA
International journal of molecular sciences
2025; 26:
128109
Ellipsoid Zone Loss as an Outcome Measure in MAK-Associated Retinitis Pigmentosa
Duong J
American Journal of Ophthalmology
2025; 278: 282-291
128162
Divergent Manifestations in Biallelic Versus Monoallelic Variants of RP1-, BEST1-, and PROM1-Associated Retinal Disorders
Exinor A
International journal of molecular sciences
2025; 26:
128109
Ellipsoid Zone Loss as an Outcome Measure in MAK-Associated Retinitis Pigmentosa
Hou B
American Journal of Ophthalmology
2025; 278: 282-291
128162
Divergent Manifestations in Biallelic Versus Monoallelic Variants of RP1-, BEST1-, and PROM1-Associated Retinal Disorders
Demirkol A
International journal of molecular sciences
2025; 26:
128109
Ellipsoid Zone Loss as an Outcome Measure in MAK-Associated Retinitis Pigmentosa
Piamjitchol C
American Journal of Ophthalmology
2025; 278: 282-291
128162
Divergent Manifestations in Biallelic Versus Monoallelic Variants of RP1-, BEST1-, and PROM1-Associated Retinal Disorders
Tsang SH
International journal of molecular sciences
2025; 26:
128109
Ellipsoid Zone Loss as an Outcome Measure in MAK-Associated Retinitis Pigmentosa
Demirkol A; Brodie SE; Sparrow JR; Tsang SH
American Journal of Ophthalmology
2025; 278: 282-291
Issue
25-3
Table of Contents
Editor's Selection
PDF
EPUB
Change Issue
26-1
25-4
25-3
25-2
25-1
24-4
24-3
24-1/2
23-4
23-3
23-2
23-1
22-4
22-3
22-2
22-1
21-4
21-3
21-2
21-1
20-4
20-3
20-2
20-1
19-4
19-3
19-2
19-1
18-4
18-3
18-2
18-1
17-4
17-3
17-2
17-1
16-4
16-3
16-2
16-1
15-4
15-3
15-2
15-1
14-4
14-3
14-2
14-1
13-4
13-3
13-2
13-1
12-4
12-3
12-2
12-1
11-4
11-3
11-2
11-1
10-4
10-3
10-2
10-1
9-4
9-3
9-2
9-1
8-4
8-3
8-2
8-1
7-3
7-2
7-1
6-3
6-2
6-1
5-3
5-2
5-1
4-3
4-2
4-1
3-3
3-2
3-1
2-3
2-2
2-1
1-3
1-2
1-1
advertisement
We would like to use Google Analytics to see which parts of the review are read. It is only used to count visits, never for advertising.
Privacy statement
Decline
Accept